Benefits
BPH Symptom Improvement
Multiple trials (Schneider 2004, Lopatkin 2005) show nettle root improves BPH symptoms vs placebo. Often combined with saw palmetto (Prostagutt forte® / PRO 160/120 — 160 mg saw palmetto + 120 mg nettle root) — major European phytotherapy product.
SHBG Binding (Free Testosterone Theoretical)
Nettle root lignans bind to sex hormone-binding globulin (SHBG) — theoretically displacing testosterone and increasing free (active) testosterone. Mechanism cited for testosterone-supportive marketing. Clinical translation modest.
5-Alpha-Reductase Inhibition (Modest)
Nettle root modestly inhibits 5-alpha-reductase — same enzyme targeted by finasteride; reduces DHT formation. Component of mechanism for BPH benefits.
Aromatase Inhibition (Modest)
Some evidence for modest aromatase inhibition — reducing testosterone-to-estrogen conversion. Relevant for some men's health applications.
Urinary Symptom Improvement
Beyond BPH, may help functional urinary symptoms — frequency, urgency, nocturia. Used in some traditions for general urinary support.
Mechanism of action
SHBG Binding
Nettle root lignans bind SHBG with significant affinity in vitro — theoretically displacing testosterone and increasing free testosterone. In vivo significance debated; protein binding alterations have complex pharmacokinetic effects.
5-Alpha-Reductase Modulation
Modestly inhibits 5-alpha-reductase, reducing DHT formation. Less potent than finasteride but contributes to BPH effects.
Anti-Inflammatory in Prostate Tissue
Reduces inflammation in prostatic tissue — relevant for BPH (which has inflammatory component) and chronic prostatitis.
UDA Lectin Effects
Urtica dioica agglutinin (UDA) is a lectin with multiple cellular effects including immune modulation. Significance in supplementation context unclear.
Clinical trials
RCT of nettle root + saw palmetto combination (PRO 160/120) vs placebo in 257 BPH patients for 24 weeks.
257 BPH patients.
Significant improvement in IPSS (International Prostate Symptom Score), urinary flow, residual urine vs placebo. Combined product limits attribution to nettle root alone. Established Prostagutt as evidence-based European BPH product.
RCT of nettle root extract alone vs placebo in 620 BPH patients for 6 months.
620 BPH patients.
Significant improvement in BPH symptoms, urinary flow, post-void residual vs placebo. Established standalone nettle root efficacy.
About this ingredient
STINGING NETTLE (Urtica dioica) is a perennial flowering plant native to Europe, North America, and parts of Asia and Africa. CRITICAL DISTINCTION between plant parts: (1) NETTLE LEAF — used for ALLERGIES, JOINT PAIN, anti-inflammatory; histamine modulation; entirely different supplementation context; (2) NETTLE ROOT — used for BPH, MALE HORMONE MODULATION, urinary support; entirely different active compounds. THIS ENTRY ADDRESSES NETTLE ROOT specifically — verify product specifies ROOT not leaf when seeking BPH/men's health benefits.
KEY ACTIVE COMPOUNDS: (1) LIGNANS — including secoisolariciresinol, isolariciresinol; bind SHBG; (2) UDA (URTICA DIOICA AGGLUTININ) — a LECTIN with multiple cellular effects; (3) BETA-SITOSTEROL — phytosterol component; (4) POLYSACCHARIDES; (5) Beta-sitosterol-3-O-glucoside. EUROPEAN BRANDED FORM: PROSTAGUTT FORTE® / PRO 160/120 — 160 mg saw palmetto + 120 mg nettle root extract; major European phytotherapy product for BPH; substantial clinical evidence base.
EVIDENCE-BASED USES: (1) BPH SYMPTOMS — modest evidence; (2) Combined with saw palmetto, pygeum, beta-sitosterol for prostate formulas; (3) Mild urinary symptoms; (4) Theoretical free testosterone increase via SHBG binding.
CRITICAL CAUTIONS: (1) NETTLE LEAF VS ROOT — these are DIFFERENT supplements with DIFFERENT uses; verify product specifies which part is used; cheap unstandardized 'nettle' products may not specify and may have variable content; (2) BPH MEDICAL EVALUATION — new urinary symptoms warrant medical workup to rule out prostate cancer, UTI, etc; supplements should not delay diagnosis; (3) PSA EFFECTS — minimal; less than finasteride; relevant for prostate cancer screening; (4) PROSTATE CANCER — nettle root is for BPH not cancer; appropriate cancer screening (PSA, DRE) regardless; (5) PREGNANCY — nettle (especially leaf) historically used as emmenagogue and uterine stimulant; AVOID supplementation in pregnancy; (6) DIABETES — modest hypoglycemic effect; monitor; (7) HORMONE-SENSITIVE CONDITIONS — theoretical effects; consult; (8) ANTIHYPERTENSIVES — modest additive effect; monitor; (9) DOSE — 300-600 mg/day standardized root extract; 240-600 mg/day in combination products; (10) DURATION — typically long-term (6+ months) for chronic BPH management; (11) STINGING — fresh nettle plant has stinging trichomes; supplements use processed/dried material with no stinging issue; (12) IMPORTANT POINT: nettle root is FOUNDATIONAL component of European phytotherapy for BPH alongside saw palmetto, pygeum, beta-sitosterol — these herbs have been studied individually and in combination for decades; reasonable evidence base; (13) The 'nettle leaf' supplement is for entirely different conditions (allergies, joint pain, hay fever) — don't confuse the two supplements.